HKU Scholars Hub: Browsing DSpace

Browsing by Author Olsson, SE

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 4 to 8 of 8 < previous

	Title	Author(s)	Issue Date	Views
	HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine Journal:Vaccine	Joura, EA Kjaer, SK Wheeler, CM Sigurdsson, K Iversen, OE HernandezAvila, M Perez, G Brown, DR Koutsky, LA Tay, EH García, P Ault, KA Garland, SM Leodolter, S Olsson, SE Tang, GWK Ferris, DG Paavonen, J Lehtinen, M Steben, M Bosch, X Dillner, J Kurman, RJ Majewski, S Muñoz, N Myers, ER Villa, LL Taddeo, FJ Roberts, C Tadesse, A Bryan, J Lupinacci, LC Giacoletti, KED Lu, S Vuocolo, S Hesley, TM Haupt, RM Barr, E	2008	83
	Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women Journal:Journal of the National Cancer Institute	Munoz, N Kjaer, SK Sigurdsson, K Iversen, OE HernandezAvila, M Wheeler, CM Perez, G Brown, DR Koutsky, LA Tay, EH Garcia, PJ Ault, KA Garland, SM Leodolter, S Olsson, SE Tang, GWK Ferris, DG Paavonen, J Steben, M Bosch, FX Dillner, J Huh, WK Joura, EA Kurman, RJ Majewski, S Myers, ER Villa, LL Taddeo, FJ Roberts, C Tadesse, A Bryan, JT Lupinacci, LC Giacoletti, KED Sings, HL James, MK Hesley, TM Barr, E Haupt, RM	2010	129
	The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years Journal:Journal of Infectious Diseases	Brown, DR Kjaer, SK Sigurdsson, K Iversen, OE Mauricio, HA Wheeler, CM Perez, G Koutsky, LA Tay, EH Garcia, P Ault, KA Garland, SM Leodolter, S Olsson, SE Tang, GWK Ferris, DG Paavonen, J Steben, M Bosch, FX Dillner, J Joura, EA Kurman, RJ Majewski, S Muñoz, N Myers, ER Villa, LL Taddeo, FJ Roberts, C Tadesse, A Bryan, J Lupinacci, LC Giacoletti, KED Sings, HL James, M Hesley, TM Barra, E	2009	263
	The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine hpv types in sexually active women aged 16-26 years Journal:Journal of Infectious Diseases	Wheeler, CM Kjaer, SK Sigurdsson, K Iversen, OE Mauricio, HA Perez, G Brown, DR Koutsky, LA Tay, EH García, P Ault, KA Garland, SM Leodolter, S Olsson, SE Tang, GWK Ferris, DG Paavonen, J Steben, M Bosch, FX Dillner, J Joura, EA Kurman, RJ Majewski, S Muñoz, N Myers, ER Villa, LL Taddeo, FJ Roberts, C Tadesse, A Bryan, J Lupinacci, LC Giacoletti, KED James, M Vuocolo, S Hesley, TM Barra, E	2009	196
	A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions Journal:Cancer Prevention Research	Kjaer, SK Sigurdsson, K Iversen, OE HernandezAvila, M Wheeler, CM Perez, G Brown, DR Koutsky, LA Eng, HT García, P Ault, KA Garland, SM Leodolter, S Olsson, SE Tang, GWK Ferris, DG Paavonen, J Lehtinen, M Steben, M Bosch, FX Dillner, J Joura, EA Majewski, S Muñoz, N Myers, ER Villa, LL Taddeo, FJ Roberts, C Tadesse, A Bryan, J Maansson, R Lu, S Vuocolo, S Hesley, TM Saah, A Barr, E Haupt, RM	2009	192

Showing results 4 to 8 of 8 < previous